The global industry for intraosseous infusion devices is poised for substantial growth, with an estimated value of USD 5,065.8 million in 2025. The market is expected to reach USD 10,463.8 million by 2035, reflecting a robust compound annual growth rate (CAGR) of 7.5% over the forecast period from 2025 to 2035.
In 2024, the intraosseous infusion devices industry generated revenues of USD 4,725.6 million, laying a solid foundation for the anticipated upward trajectory. Intraosseous infusion devices, which enable rapid access to the bone marrow for drug and fluid delivery, are increasingly being adopted in emergency medical care, especially in critical settings like trauma, cardiac arrest, and pediatric emergencies.
Get Ahead of Market Shifts: Request Your Sample Report! https://www.futuremarketinsights.com/report-sample#5245502d47422d31353639
The market’s growth is driven by several key factors, including advancements in medical technology, increased awareness of the benefits of intraosseous infusion, and growing demand for rapid emergency care in both developed and emerging markets. The technology is gaining prominence due to its ability to provide life-saving solutions in cases where traditional intravenous (IV) access is difficult or impossible.
Moreover, as healthcare providers across the globe continue to seek faster, more reliable methods of fluid and medication administration during emergencies, the intraosseous infusion market will likely see a steady increase in both adoption and innovation. The expansion of this market, particularly in developing regions, will present considerable opportunities for manufacturers and healthcare practitioners alike.
This market growth reflects both the rising need for rapid medical interventions and the ongoing evolution of medical devices designed to meet those demands. Healthcare systems worldwide are expected to continue integrating intraosseous infusion devices into their emergency protocols, driving further market expansion in the years to come.
Key Takeaways: Intraosseous Infusion Devices Market
- The global market for intraosseous infusion devices is projected to grow from USD 5,065.8 million in 2025 to USD 10,463.8 million by 2035, representing a robust compound annual growth rate (CAGR) of 7.5% during the forecast period (2025–2035).
- Regional Growth Highlights:
- United States: Anticipated to experience a CAGR of 7.4% from 2025 to 2035.
- Germany: Expected to grow at a slightly higher rate with a CAGR of 8.0% during the same period.
- China: Projected to witness a 7.6% CAGR, contributing significantly to the market.
- France: Expected to experience a steady CAGR of 7.8%.
- India: Anticipated to lead the growth with the highest CAGR of 8.7%, reflecting strong market expansion.
- Spain: Forecasted to grow at a 7.2% CAGR, showing moderate growth.
- Australia & New Zealand: Projected to grow at 7.3% CAGR, aligning with overall market growth.
- South Korea: Predicted to witness a CAGR of 8.2%, reflecting a strong demand in the region.
- Revenue Outlook: The market is on track for significant expansion, with strong regional contributions expected from both developed and emerging economies.
“The global intraosseous infusion devices market is set for dynamic growth in the next decade. The 7.5% CAGR forecast underscores the rising adoption of this technology, driven by improvements in device safety, efficiency, and training among healthcare professionals. In particular, the surge in critical care needs and advancements in medical protocols are expected to accelerate the use of intraosseous infusion in emergency medicine,” says Sabyasachi Ghosh Associate Vice President at Future Market Insights (FMI) analyst.
Elevated Market Interest: Delve into In-Depth Trends and Insights with Our Full Report! https://www.futuremarketinsights.com/reports/intraosseous-infusion-devices-market
Competitive Landscape:
Companies in the intraosseous infusion device market are actively strengthening their positions through various strategic initiatives, such as collaborations, mergers and acquisitions, FDA approvals, and partnerships with both established and emerging players. These strategies enable manufacturers to expand their market share and capture significant portions of the growing market.
Recent Industry Developments in the Intraosseous Infusion Devices Industry:
- March 2023: BD launched a new intraosseous (IO) system featuring an integrated passive needle tip safety mechanism, designed to protect against needlestick injuries. The system also includes a rechargeable, battery-powered driver with a multi-light battery indicator for instant charge status visibility.
- 2024: The FAST1™ intraosseous infusion system by Teleflex remains a leading product, with notable enhancements made for sternal IO access, particularly beneficial during CPR and trauma care.
Key Players of Intraosseous Infusion Devices Market:
- Pyng Medical Corp.
- Biopsybell
- Cook Medical Incorporated
- PAVmed
- PerSys Medical
- Aero Healthcare
- Teleflex, Inc.
- Becton Dickinson and Company
- SAM Medical
- Cardinal Health, Inc.
Future-Proof Your Healthcare Business with Our Reports! https://www.futuremarketinsights.com/industry-analysis/therapeutic-device
Key Segments of Intraosseous Infusion Devices Industry:
By Product:
In terms of product, the industry is divided into- B.I.G, FAST1, EZ-IO, FASTR, IO Needles and Others .
By Route of Administration:
In terms of route of administration, the industry is segregated into sternum, distal & proximal tibia, distal femur, calcaneus and head of humerus
By Technology:
In terms of technology, the industry is segregated into- manual and automatic ( impact driven and power drill )
By End User:
In terms of end user, the industry is segregated into EMS, hospitals, ambulatory surgical centers and cardiac care centers
By Region:
Key countries of North America, Latin America, Western Europe, Eastern Europe, South Asia and Pacific, East Asia and Middle East and Africa (MEA) have been covered in the report.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube